• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 25-NSE filed by Strata Critical Medical Inc.

    5/6/26 4:04:39 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary
    Get the next $SRTA alert in real time by email
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    UNITED STATES
    OMB APPROVAL
    OMB Number: 3235-0080
    Expires: March 31, 2018
    Estimated average burden
    hours per response: 1.7
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 25
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
    UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    Commission File Number 001-39046
    Issuer: Strata Critical Medical, Inc.
    Exchange: Nasdaq Stock Market LLC
    (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
    Address: 666 Third Avenue
    25th Floor
    New York NEW YORK 10017
    Telephone number: 212-967-1009
    (Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
    Warrants expiring 05/07/2026
    (Description of class of securities)
    Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
    17 CFR 240.12d2-2(a)(1)
    17 CFR 240.12d2-2(a)(2)
    17 CFR 240.12d2-2(a)(3)
    17 CFR 240.12d2-2(a)(4)
    Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
    Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
    Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
    2026-05-06 By Jennifer Fainer CDO Analyst
    Date Name Title
    1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $SRTA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SRTA

    DatePrice TargetRatingAnalyst
    3/25/2026$8.00Buy
    Craig Hallum
    3/25/2026$8.00Buy
    B. Riley Securities
    12/2/2025$8.00Buy
    Lake Street
    More analyst ratings

    $SRTA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Craig Hallum initiated coverage on Strata Critical Medical with a new price target

    Craig Hallum initiated coverage of Strata Critical Medical with a rating of Buy and set a new price target of $8.00

    3/25/26 8:36:47 AM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    B. Riley Securities initiated coverage on Strata Critical Medical with a new price target

    B. Riley Securities initiated coverage of Strata Critical Medical with a rating of Buy and set a new price target of $8.00

    3/25/26 8:35:45 AM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    Lake Street resumed coverage on Strata Critical Medical with a new price target

    Lake Street resumed coverage of Strata Critical Medical with a rating of Buy and set a new price target of $8.00

    12/2/25 8:39:50 AM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    $SRTA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Cohen Amir sold $299,435 worth of shares (50,875 units at $5.89) as part of a pre-agreed trading plan, decreasing direct ownership by 25% to 151,263 units (SEC Form 4)

    4 - Strata Critical Medical, Inc. (0001779128) (Issuer)

    5/26/26 4:49:55 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    Chief Accounting Officer Cohen Amir sold $82,832 worth of shares (14,306 units at $5.79) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 202,138 units (SEC Form 4)

    4 - Strata Critical Medical, Inc. (0001779128) (Issuer)

    5/13/26 4:04:46 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    SEC Form 4 filed by Large owner Krstic Velibor

    4 - Strata Critical Medical, Inc. (0001779128) (Issuer)

    5/8/26 4:08:02 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    $SRTA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Strata Acquires Louisville Perfusion Services

    NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company")), today announced that it has completed the acquisition of Louisville Perfusion Services, Inc. ("LPS"), a regional provider of perfusion and blood management services to cardiac surgery programs in Kentucky. "The acquisition of Louisville Perfusion Services fits perfectly with our existing customer base in Kentucky and Ohio, giving us a new strategic stronghold in the Midwest and Southern United States," said Lou Verdetto, CEO of Strata's Clinical Division. "More than just unlocking the ability to win new perfusion contracts in the region, LPS also expands the national footpr

    6/2/26 9:00:00 AM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    Strata Critical Medical Announces Expiration of Warrants

    NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company")), announced that its warrants, both the Public Warrants (NASDAQ:SRTAW) and the Private Placement Warrants, expired in accordance with their original terms at 5:00 p.m. Eastern Time today May 7, 2026. About Strata Critical Medical, Inc. Strata is a time-critical logistics and medical services provider to the U.S. healthcare industry. We operate one of the nation's largest air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated "one call" solution for donor organ recovery. Strata's core services include

    5/7/26 5:05:00 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    Strata Critical Medical Announces First Quarter 2026 Results

    Revenue increased 87.4% year-over-year to $67.4 million in Q1 2026Logistics revenue and gross profit grew 32.4% and 29.9% year-over-year, respectively, in Q1 2026, which represents Strata's organic growthClinical revenue and gross profit sequential growth of 12.7% and 29.2%, respectively in Q1 2026 versus Q4 2025 Q1 2026 net income from continuing operations of $2.4 millionAdjusted EBITDA(1) of $6.4 million in Q1 2026Completed bolt-on acquisition of Ohio Valley Perfusion AssociatesReiterating full year 2026 guidance NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, ", Strata", or the ", Company", )), today announced financial results for the first quar

    5/6/26 7:00:00 AM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    $SRTA
    SEC Filings

    View All

    Strata Critical Medical Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Strata Critical Medical, Inc. (0001779128) (Filer)

    6/3/26 4:25:12 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    SEC Form 25-NSE filed by Strata Critical Medical Inc.

    25-NSE - Strata Critical Medical, Inc. (0001779128) (Subject)

    5/6/26 4:04:39 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    SEC Form 10-Q filed by Strata Critical Medical Inc.

    10-Q - Strata Critical Medical, Inc. (0001779128) (Filer)

    5/6/26 11:53:32 AM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    $SRTA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-CEO and CFO Heyburn William A. bought $76,044 worth of shares (17,000 units at $4.47), increasing direct ownership by 1% to 1,403,436 units (SEC Form 4)

    4 - Strata Critical Medical, Inc. (0001779128) (Issuer)

    12/10/25 4:15:25 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    Director Lauck Andrew bought $21,825 worth of shares (5,000 units at $4.37), increasing direct ownership by 4% to 135,642 units (SEC Form 4)

    4 - Strata Critical Medical, Inc. (0001779128) (Issuer)

    12/5/25 4:21:01 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    $SRTA
    Leadership Updates

    Live Leadership Updates

    View All

    Strata Critical Medical, Inc. Appoints Will Cook to Board of Directors

    NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The Board of Directors (the "Board") of Strata Critical Medical, Inc. ("Strata" or the "Company"), a leading provider of logistics and medical services in the organ transplant industry, today announced the appointment of Will Cook to the Board, effective December 3, 2025. Mr. Cook has also been appointed to the Compensation and Nominating and Corporate Governance Committees. Mr. Cook is the President and Chief Executive Officer of Vail Health, a nonprofit community health care system headquartered in Vail, Colorado. "We are very excited to welcome Will Cook to our board of directors," said Melissa Tomkiel, Strata's Co-Chief Executive Office

    12/3/25 5:00:00 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    $SRTA
    Financials

    Live finance-specific insights

    View All

    Strata Acquires Louisville Perfusion Services

    NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company")), today announced that it has completed the acquisition of Louisville Perfusion Services, Inc. ("LPS"), a regional provider of perfusion and blood management services to cardiac surgery programs in Kentucky. "The acquisition of Louisville Perfusion Services fits perfectly with our existing customer base in Kentucky and Ohio, giving us a new strategic stronghold in the Midwest and Southern United States," said Lou Verdetto, CEO of Strata's Clinical Division. "More than just unlocking the ability to win new perfusion contracts in the region, LPS also expands the national footpr

    6/2/26 9:00:00 AM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    Strata Critical Medical Announces First Quarter 2026 Results

    Revenue increased 87.4% year-over-year to $67.4 million in Q1 2026Logistics revenue and gross profit grew 32.4% and 29.9% year-over-year, respectively, in Q1 2026, which represents Strata's organic growthClinical revenue and gross profit sequential growth of 12.7% and 29.2%, respectively in Q1 2026 versus Q4 2025 Q1 2026 net income from continuing operations of $2.4 millionAdjusted EBITDA(1) of $6.4 million in Q1 2026Completed bolt-on acquisition of Ohio Valley Perfusion AssociatesReiterating full year 2026 guidance NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, ", Strata", or the ", Company", )), today announced financial results for the first quar

    5/6/26 7:00:00 AM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    Strata Acquires Ohio Valley Perfusion Associates

    NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, ", Strata", or the ", Company", )), today announced that it has completed the acquisition of Ohio Valley Perfusion Associates ("OVPA"), a regional provider of perfusion services to cardiac surgery programs in Ohio and Pennsylvania. "Expanding our presence in Eastern Ohio and Western Pennsylvania is an important step in strengthening Strata's regional clinical platform," said Louis Verdetto, CEO of Strata's Clinical Services Division. "These programs align well with our existing operations and allow us to further leverage our team of highly trained perfusionists to support cardiac surgery programs whil

    4/30/26 4:05:00 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary